Wafa N. Al‐Nassir

2.7k total citations · 1 hit paper
7 papers, 1.7k citations indexed

About

Wafa N. Al‐Nassir is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Wafa N. Al‐Nassir has authored 7 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 3 papers in Epidemiology and 1 paper in Molecular Biology. Recurrent topics in Wafa N. Al‐Nassir's work include Clostridium difficile and Clostridium perfringens research (6 papers), Infection Control in Healthcare (3 papers) and Microscopic Colitis (3 papers). Wafa N. Al‐Nassir is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (6 papers), Infection Control in Healthcare (3 papers) and Microscopic Colitis (3 papers). Wafa N. Al‐Nassir collaborates with scholars based in United States, United Kingdom and Saudi Arabia. Wafa N. Al‐Nassir's co-authors include Curtis J. Donskey, Ajay K. Sethi, Sami Al-Hajjar, Hanan H. Balkhy, Hatem Q. Makhdoom, Abdullah M. Assiri, Rafat F. Alhakeem, Alimuddin Zumla, Ziad A. Memish and Fahad Alrabiah and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and The Lancet Infectious Diseases.

In The Last Decade

Wafa N. Al‐Nassir

7 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study

2013 1.0k citations Abdullah M. Assiri, Jaffar A. Al‐Tawfiq et al. The Lancet Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wafa N. Al‐Nassir United States	6	1.5k	587	222	187	170	7	1.7k
Julien Poissy France	21	1.4k 0.9×	645 1.1×	310 1.4×	180 1.0×	117 0.7×	72	2.2k
KI Law China	7	1.5k 1.0×	320 0.5×	323 1.5×	57 0.3×	251 1.5×	9	2.0k
Poon Chuen Wong China	12	1.1k 0.7×	559 1.0×	153 0.7×	42 0.2×	131 0.8×	15	1.4k
Abdullah A Al-Rabeeah Saudi Arabia	13	1.7k 1.1×	399 0.7×	275 1.2×	56 0.3×	442 2.6×	17	2.2k
Nadhira Houhou‐Fidouh France	13	1.2k 0.8×	351 0.6×	131 0.6×	52 0.3×	109 0.6×	24	1.6k
Ilana Tal Israel	12	833 0.5×	228 0.4×	106 0.5×	58 0.3×	150 0.9×	16	1.5k
Adel Alothman Saudi Arabia	16	585 0.4×	250 0.4×	108 0.5×	70 0.4×	81 0.5×	47	966
Katherine R. W. Emary United Kingdom	11	1.1k 0.7×	208 0.4×	126 0.6×	22 0.1×	181 1.1×	22	1.7k
Nandini Sethuraman India	9	1.1k 0.7×	260 0.4×	141 0.6×	42 0.2×	92 0.5×	24	1.4k
Khetam Hussein Israel	20	636 0.4×	442 0.8×	106 0.5×	103 0.6×	47 0.3×	60	1.7k

Countries citing papers authored by Wafa N. Al‐Nassir

Since Specialization

Citations

This map shows the geographic impact of Wafa N. Al‐Nassir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wafa N. Al‐Nassir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wafa N. Al‐Nassir more than expected).

Fields of papers citing papers by Wafa N. Al‐Nassir

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wafa N. Al‐Nassir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wafa N. Al‐Nassir. The network helps show where Wafa N. Al‐Nassir may publish in the future.

Co-authorship network of co-authors of Wafa N. Al‐Nassir

This figure shows the co-authorship network connecting the top 25 collaborators of Wafa N. Al‐Nassir. A scholar is included among the top collaborators of Wafa N. Al‐Nassir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wafa N. Al‐Nassir. Wafa N. Al‐Nassir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Assiri, Abdullah M., Jaffar A. Al‐Tawfiq, Abdullah A Al-Rabeeah, et al.. (2013). Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. The Lancet Infectious Diseases. 13(9). 752–761. 1048 indexed citations breakdown →

2.

Sethi, Ajay K., et al.. (2009). Persistence of Skin Contamination and Environmental Shedding ofClostridium difficileduring and after Treatment of C.difficileInfection. Infection Control and Hospital Epidemiology. 31(1). 21–27. 220 indexed citations

3.

Al‐Nassir, Wafa N., et al.. (2008). Comparison of Clinical and Microbiological Response to Treatment ofClostridium difficile–Associated Disease with Metronidazole and Vancomycin. Clinical Infectious Diseases. 47(1). 56–62. 122 indexed citations

4.

Sethi, Ajay K., Wafa N. Al‐Nassir, Michelle M. Nerandzic, & Curtis J. Donskey. (2008). Skin and Environmental Contamination With Vancomycin-Resistant Enterococci in Patients Receiving Oral Metronidazole or Oral Vancomycin Treatment forClostridium difficile–Associated Disease. Infection Control and Hospital Epidemiology. 30(1). 13–17. 45 indexed citations

5.

Al‐Nassir, Wafa N., et al.. (2008). Both Oral Metronidazole and Oral Vancomycin Promote Persistent Overgrowth of Vancomycin-Resistant Enterococci during Treatment of Clostridium difficile -Associated Disease. Antimicrobial Agents and Chemotherapy. 52(7). 2403–2406. 198 indexed citations

6.

Al‐Nassir, Wafa N.. (2007). Metronidazole treatment failure in Clostridium difficile -associated disease is associated with suboptimal microbiologic response. 1 indexed citations

7.

Al‐Nassir, Wafa N., et al.. (2007). Clostridium difficile Skin Contamination in Patients with C. difficile-Associated Disease. Clinical Infectious Diseases. 46(3). 447–450. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact